Loading
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
Latest quote
$0.5212
−$0.0276 · -5.03%
Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-related products), and veterinary care items.
Previous close
$0.5212
−$0.0276 · -5.03%
Regular session · ET · Market data may be delayed.
Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-related products), and veterinary care items.
Day range
Current $0.5212
52-week range
Current $0.5212
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
23
Expensive
Sentiment
53
Mixed
Risk
63
High Risk
Momentum
18
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-related products), and veterinary care items.
Day range
Current $0.5212
52-week range
Current $0.5212
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (AUD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 165.65K AUD | — | 79.84K AUD | 147.54K AUD | — |
| Cost of goods sold | — | — | 48.93K AUD | 94.87K AUD | — |
| Gross profit | 165.65K AUD | — | 30.92K AUD | 52.66K AUD | — |
| Research and development | 628.61K AUD | 276.06K AUD | 665.04K AUD | 529.02K AUD | 277.06K AUD |
| Selling, general, and administrative | 2.22M AUD | 1.27M AUD | 1.7M AUD | 1.55M AUD | 463.73K AUD |
| Operating expenses | 5.66M AUD | 2.95M AUD | 3.13M AUD | 3.25M AUD | 647.62K AUD |
| Interest expense | 1.89M AUD | 585.12K AUD | 403.52K AUD | 174.5K AUD | 1.3K AUD |
| Depreciation and amortization | 1.27M AUD | 1.16M AUD | 1.21M AUD | 1.22M AUD | 57.95K AUD |
| Operating income | −5.5M AUD | −2.95M AUD | −3.1M AUD | −3.19M AUD | −647.62K AUD |
| Net income | −6.65M AUD | −3.55M AUD | −3.51M AUD | −3.37M AUD | −648.92K AUD |
Company facts updated Oct 10, 2026.
Reported history and fiscal-year consensus
Reported history and fiscal-year consensus
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
